Workplace Drug/Alcohol Prevention Services: Management Services

Bensinger, DuPont and Associates provides a range of management services designed to ensure that employer programs meet legal and good practice standards and that employers clearly understand the scope, nature and impact of their efforts. BDA offers a range of management programs.

Policy Development and Review
For employers beginning a new program - consultation with employers regarding scope and direction of proposed program; development of draft policy and supporting programs; review of legal and other requirements and identification of third party providers as necessary, identifying training requirements and criteria; and, establishing employee communication requirements.

For employers with an existing program - review of policy to ensure compliance with appropriate regulations and with current "good practice;" review of training requirements for employees, supervisors and senior management; review of current program providers; review of Federal and state regulatory responses; and, review of the employee communications efforts.

Management Briefings
Briefings to senior management on trends in business and industry, regulatory requirements and outlook, an overview of the employer's program and its comparison to other workplace programs, and a review of the key elements of the current company programs. Briefings provided by Peter B. Bensinger, BDA President and CEO, Robert L. DuPont, M.D., BDA Executive Vice President and Medical Director, and other senior BDA staff.

Expert Testimony
BDA provides expert testimony for arbitration and judicial hearings. BDA officials and associates currently provide expert testimony in the following areas:

BDA personnel have extensive experience as expert witnesses. President and CEO Peter B. Bensinger has testified on matters pertaining to policy, program implementation, and administrative standards in over 30 arbitrations, administrative hearings and court cases. Robert L. DuPont, M.D., BDA Senior Vice President and Medical Director has testified in over 50 instances regarding the effect of drugs on human beings, drug testing results, and medical review issues. Larry B. Howard, BDA chief toxicologist has testified in over 300 cases regarding issues of forensic toxicology. Other BDA associates who are physicians, toxicologists, and health-care managers have also testified in court and arbitration hearings.

Teleconferences
Current BDA clients are invited to join periodic teleconferences on subjects related to workplace drug prevention programs. These teleconferences are moderated by Dr. Robert DuPont, BDA Executive Vice President and Medical Director, and draw upon experts from industry, government, and the research and treatment communities.

Return to Workplace Drug/Alcohol Prevention